|
|
Volumn 171, Issue 11, 2014, Pages 1222-
|
|
The impact of benzodiazepine management in the randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPRAZOLAM;
BENZODIAZEPINE;
CYCLOSERINE;
ANXIOLYTIC AGENT;
DRUG ABUSE;
DRUG EFFICACY;
DRUG INDICATION;
DRUG SAFETY;
DRUG WITHDRAWAL;
HUMAN;
LETTER;
LOW DRUG DOSE;
POSTTRAUMATIC STRESS DISORDER;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SAMPLE SIZE;
SCREENING;
TREATMENT RESPONSE;
VETERANS HEALTH;
VIRTUAL REALITY EXPOSURE THERAPY;
FEMALE;
MALE;
PROCEDURES;
PSYCHOLOGY;
STRESS DISORDERS, POST-TRAUMATIC;
VETERAN;
ALPRAZOLAM;
ANTI-ANXIETY AGENTS;
CYCLOSERINE;
FEMALE;
HUMANS;
MALE;
STRESS DISORDERS, POST-TRAUMATIC;
VETERANS;
VIRTUAL REALITY EXPOSURE THERAPY;
|
|
EID: 84910115410
PISSN: 0002953X
EISSN: 15357228
Source Type: Journal
DOI: 10.1176/appi.ajp.2014.14070821 Document Type: Letter |
|
Times cited : (1)
|
|
References (2)
|
